nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Apoptosis of Raji cells by an anti-CD20 antibody HI47 and its fragments
|
Liu, Yin-Xing |
|
2004 |
28 |
2 |
p. 209-211 3 p. |
artikel |
2 |
Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biology
|
Nieva, Jorge |
|
2004 |
28 |
2 |
p. 113-114 2 p. |
artikel |
3 |
Classification of refractory anemia
|
Finn, William G |
|
2004 |
28 |
2 |
p. 213- 1 p. |
artikel |
4 |
Comment to Letter by W.G. Finn: 03-D-849
|
Bennett, John M |
|
2004 |
28 |
2 |
p. 215- 1 p. |
artikel |
5 |
Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr–abl tyrosine kinase
|
Pattacini, Laura |
|
2004 |
28 |
2 |
p. 191-202 12 p. |
artikel |
6 |
Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics
|
Trost, Detlef |
|
2004 |
28 |
2 |
p. 171-177 7 p. |
artikel |
7 |
Identification of a S100 calcium-binding protein expressed in HL-60 cells treated with all-trans retinoic acid by two-dimensional electrophoresis and mass spectrometry
|
Wu, Yuzhang |
|
2004 |
28 |
2 |
p. 203-207 5 p. |
artikel |
8 |
Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR)
|
El-Obeid, Adila |
|
2004 |
28 |
2 |
p. 133-137 5 p. |
artikel |
9 |
Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma
|
Wun, Ted |
|
2004 |
28 |
2 |
p. 179-190 12 p. |
artikel |
10 |
Inhibition of cyclooxygenase-2: a new targeted therapy for B-cell lymphoma?
|
Phipps, Richard P |
|
2004 |
28 |
2 |
p. 109-111 3 p. |
artikel |
11 |
Interleukin 4 production by peripheral blood lymphocytes in patients with classical Hodgkin lymphoma
|
Mainou-Fowler, T |
|
2004 |
28 |
2 |
p. 159-166 8 p. |
artikel |
12 |
Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AML
|
Zheng, Rui |
|
2004 |
28 |
2 |
p. 121-126 6 p. |
artikel |
13 |
MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia
|
Yokoyama, Akihiro |
|
2004 |
28 |
2 |
p. 149-157 9 p. |
artikel |
14 |
Monitoring treatment efficiency in MDS at the molecular level; possibilities now and in the future
|
van Dijk, Jeroen P |
|
2004 |
28 |
2 |
p. 101-108 8 p. |
artikel |
15 |
Non-treatment-related chronic myeloid leukemia as a second malignancy
|
Specchia, Giorgina |
|
2004 |
28 |
2 |
p. 115-119 5 p. |
artikel |
16 |
Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML)
|
Kang, Hyoung Jin |
|
2004 |
28 |
2 |
p. 167-170 4 p. |
artikel |
17 |
Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo
|
Friedberg, Jonathan W |
|
2004 |
28 |
2 |
p. 139-147 9 p. |
artikel |
18 |
Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine
|
Pardanani, A |
|
2004 |
28 |
2 |
p. 127-131 5 p. |
artikel |